Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin

Collin M Costello; Connor J Maly; Sam Snider; Kevin J Severson; David J DiCaudo; Allison C Rosenthal; Donald W Northfelt; William Rule; Fiona E Craig; Mark R Pittelkow; Aaron R Mangold

doi:10.1016/j.jdcr.2019.10.022

Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin

JAAD Case Rep. 2019 Dec 24;6(1):19-22. doi: 10.1016/j.jdcr.2019.10.022. eCollection 2020 Jan.

Affiliations

¹ Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
² Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona.
³ Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona.
⁴ Department of Pathology, Mayo Clinic, Scottsdale, Arizona.

No abstract available

Keywords: EBV, Epstein-Barr virus; PBL, plasmablastic lymphoma; chemotherapy; pcPBL, primary cutaneous plasmablastic lymphoma; pcPTCL-NOS, primary cutaneous peripheral T-cell lymphoma not otherwise specified; plasmablastic lymphoma; primary cutaneous plasmablastic lymphoma; romidepsin.

Publication types

Case Reports